Tag
Tatva Chintan Pharma Chem Limited
2 articles
Tatva Chintan FY26 Business Responsibility Sustainability Report
Tatva Chintan submitted its standalone BRSR report for FY 2025-26 to BSE and NSE, complying with SEBI Listing Regulations.
The company reported a turnover of ₹4,962.96 million with 75% from exports an
Tatva Chintan 30th AGM Notice and Resolutions
Tatva Chintan Pharma Chem schedules its 30th AGM for 25 September 2026 to approve audited FY26 financial statements and a ₹2 per share dividend.
AGM agenda includes re-appointing three promoter-direct